Chemocentryx reported $-38233000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbvie ABBV:US $ 5029M 601M
Alnylam Pharmaceuticals ALNY:US $ -146732000 47.83M
Amgen AMGN:US $ 2500M 196M
AstraZeneca AZN:LN 2.88B 1.57B
Bayer BAYN:GR 4.17B 704M
Biogen BIIB:US $ 531.5M 11.7M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bristol Myers Squibb BMY:US $ 3188M 399M
Chemocentryx CCXI:US $ -38233000 1.82M
Glaxosmithkline GSK:US 2.42B 724M
GlaxoSmithKline GSK:LN 2.42B 724M
Johnson & Johnson JNJ:US $ 7540M 1623M
Macrogenics MGNX:US $ -66638000 8.4M
Merk MRK:US $ 5059M 207M
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Novartis NOVN:VX 3.15B 266M
Omeros OMER:US $ -35046000 65.69M
Pfizer PFE:US $ 9995M 4136M
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Takeda 4502:JP -1619000000 144.87B
Teva Pharmaceutical TEVA:IT 789M 182M
YTE INCY:US $ 127.66M 7.71M